New NIH National Cancer Institute R01 funding for global health-focused cervical cancer screening.
New NIH National Cancer Institute R01 funding for global health-focused cervical cancer screening.
| Event Date: | September 15, 2020 |
|---|
We're looking forward to working with Co-PI, Dr. Sulma Mohammed from Purdue's Comparative Pathobiology Department to translate promising new biomarker signatures from the lab to the point-of-care.
Much thanks goes to to seed funding from Purdue's Global Engineering Program, and from Indiana CTSI and Purdue Women's Global Health Institute supporting our initial collaboration with Dr. Mohammed's group.